|Share this content:|
|Home||About Us||Our Attorneys||Cases||Practice Areas||Settlement Notices||News & Events||Contact Us|
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Over $100,000 In Losses Investing In Body Central Corp. To Contact the Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Body Central Corp. (“Body Central” or the “Company”) (NasdaqGS: BODY).
The investigation focuses on whether the Company and its executives violated federal securities laws by failing to disclose that: (1) the Company’s merchandise miss was not an isolated, quickly fixable event, but would take at least several quarters to remedy and would have a material, negative impact on the Company’s financial results; (2) the Company’s stores were experiencing increasingly poor performance and financial results; and (3) Body Central executives had issued misleading statements regarding the Company’s operations and business outlook.
On May 3, 2012, Body Central published a press release announcing its first quarter 2012 financial results. In it, the Company unexpectedly issued a weak forecast for second quarter and full year earnings, citing an expected decrease in comparable store sales. For the second quarter, the Company forecast earnings between $0.26 and $0.28 cents, well below market expectations of $0.36. The Company forecasted full year earnings of $1.34 to $1.38, below the average analyst forecast of $1.52. On this news, Body Central common stock abruptly lost almost half of its value, falling $14.04 per share to close at $14.88 per share on May 4, 2012, a one-day decline of more than 48%.
Then, on June 18, 2012, Body Central issued a press release “revising sales and earning guidance for its second quarter and full year 2012.” On this news, Body Central common stock again lost almost half of its value, falling $7.77 per share from a closing price of $15.99 on June 15, 2012 to close at $8.22 per share on June 18, 2012, the next trading day – a one-day decline of more than 48% – on volume of more than 14 million shares traded.
If you purchased Body Central securities between November 10, 2011 and June 18, 2012 and would like to discuss your legal rights, contact us by calling Richard Gonnello or Francis McConville toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to email@example.com, firstname.lastname@example.org or email@example.com. Faruqi & Faruqi, LLP also encourages anyone with information regarding Body Central’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Please tell us about yourself by completing the form and we will provide you with additional
information on how to join the Class Action at no cost to you. If you want to be a Lead Plaintiff or join
this action now, please click HERE.
*The submission of this form does not create an attorney-client relationship.